medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2009, Número 3

<< Anterior Siguiente >>

Rev Inst Nal Enf Resp Mex 2009; 22 (3)


Sistema renina-angiotensina y su relación con la fibrosis pulmonar idiopática

Montes ME, Ruiz LVM

Idioma: Español
Referencias bibliográficas: 40
Paginas: 198-205
Archivo PDF: 457.93 Kb.


RESUMEN

Durante mucho tiempo se pensó que el sistema renina-angiotensina regulaba únicamente la presión arterial sistémica y el balance de electrolitos. En años recientes se ha demostrado su papel en la regulación de otros procesos a través de su efector, la angiotensina II, incluyendo patologías fibrosantes en corazón y riñón. En esta revisión presentamos evidencias novedosas de la participación del sistema renina-angiotensina en procesos fibrosantes que también podrían desempeñar un papel importante en la fibrosis pulmonar idiopática.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Selman M, Navarro C, Gaxiola M. Fibrosis pulmonar idiopática: en busca de un tratamiento eficaz. Arch Bronconeumol 2005;41 Supl 5:15-20.

  2. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517-525.

  3. Selman M, King TE, Pardo A; American Thoracic Society, European Respiratory Society, American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134:136-151.

  4. Thannickal VJ, Toews GB, White ES, Lynch JP 3rd, Martinez FJ. Mechanisms of pulmonary fibrosis. Annu Rev Med 2004;55:395-417.

  5. Selman M, Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res 2002;3:1-8.

  6. Pardo A, Selman M. Molecular mechanisms of pulmonary fibrosis. Front Biosci 2002;7:d1743-1761.

  7. Selman M, King TE, Pardo A; American Thoracic Society, European Respiratory Society, American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Inter Med 2001;134:136-151.

  8. Pardo A, Selman M. Idiopathic pulmonary fibrosis: new insights in its pathogenesis. Int J Biochem & Cell Biol 2002;34:1534-1538.

  9. Watanabe T, Barker TA, Berk BC. Angiotensin II and the endothelium: diverse signals and effects. Hypertension 2005;45:163-169.

  10. Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension 2001;38(3 Pt 2):635-638.

  11. Bataller R, Schwabe RF, Choi YH, et ál. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2003;112:1383-1394.

  12. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 2004;63: 423-432.

  13. Uhal BD, Joshi I, True AL, et ál. Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am J Physiol 1995;269(6 Pt 1):L819-L828.

  14. Li X, Rayford H, Uhal BD. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am J Pathol 2003;163:2523-2530.

  15. Wang R, Zagariya A, Ibarra-Sunga O, et ál. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol 1999;276(5 Pt 1):L885-L889.

  16. Uhal BD, Kim JK, Li X, Molina-Molina M. Angiotensin- TGF- crosstalk in human idiophatic pulmonary fibrosis: autocrine mechanism in myofibroblast and macrophages. Curr Pharm Des 2007;17:1247-1256.

  17. Marschall RP. The pulmonary renin-angiotensin system. Curr Pharm Des 2003;9:715-722.

  18. Persson PB. Renin: origin, secretion and synthesis. J Physiol 2003;552:667-671.

  19. Lavoide JL, Sigmund CD. Minireview: overview of the renin-angiotensin system an endocrine and paracrine system. Endocrinology 2003;144:2179-2183.

  20. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med 2008;264:224-236.

  21. Nguyen G, Danser AH. Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents. Exp Physiol 2008;93:557-563.

  22. Nguyen G. The (pro)renin receptor: pathophysiological roles in cardivascular and renal pathology. Curr Opin Nephrol Hypertens 2007;16:129-133.

  23. Nguyen G. Renin/prorenin receptors. Kidney Int 2006;69:1503-1506.

  24. Oliver JA. Receptor-mediated actions of renin and prorenin. Kidney Int 2006;69:13-15.

  25. Danser AH. (Pro)renin receptors: are the biologically relevant? Curr Opin Nephrol Hypertens 2009;18:74-78.

  26. Bader M. The second life of the (pro)renin receptor. J Renin Angiotensin Aldosterone Syst 2007;8:205-208.

  27. Schefe JH, Neumann C, Goebel M, et ál. Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. J Hypertens 2008;26:1787-1794.

  28. Kaneshiro Y, Ichihara A, Sakoda M, et ál. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol 2007;18:1789-1795.

  29. Melnyk RA, Tam J, Boie Y, Kennedy BP, Percival MD. Renin and prorenin activate pathways implicated in organ damage in human mesangial cells independent of angiotensin II production. Am J Nephrol 2009; 30:232-243.

  30. Burcklé CA, Jan Danser AH, Müller DN, et ál. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 2006;47:552-556.

  31. Véniant M, Ménard J, Bruneval P, Morley S, Gonzales MF, Mullins J. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 1996;98:1966-1970.

  32. Huang Y, Wongamorntham S, Kasting J, et ál. Renin increases mesangial cell transforming growth factor b-1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 2006;69:105-113.

  33. Melnyk RA, Tam J, Boie Y, Kennedy BP, Percival MD. Renin and prorenin activate pathways implicated in organ damage in human mesangial cells independent of angiotensin II production. Am J Nephrol 2009;30: 232-243.

  34. He M, Zhang L, Shao Y, et ál. Inhibition of renin/prorenin receptor attenuated mesangial cell proliferation and reduced associated fibrotic factor release. Eur J Pharmacol 2009;606:155-161.

  35. Feldt S, Batenburg WW, Mazak I, et ál. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension 2008; 51:682-688.

  36. Pilz B, Shagdarsuren E, Wellner M, et ál. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Hypertension 2005;46:569-576.

  37. Sinn PL, Sigmund CD. Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics 2000; 3:25-31.

  38. Baker KM, Chernin MI, Schreiber T, et ál. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept 2004;120:5-13.

  39. Lavrentyev EN, Estes AM, Malik KU. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ Res 2007;101:455-464.

  40. Singh VP, Baker KM, Kumar R. Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. Am J Physiol Heart Circ Physiol 2008;294:H1675-H1684.




2020     |     www.medigraphic.com